Effect of dexamethasone on the onset time and recovery profiles of cisatracurium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001519

Enrollment

117

Registered

2015-06-10

Start date

2014-12-23

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : All patients were pre-medicated with midazolam 0.05 mg/kg, intramuscularly, 30 minute before anesthesia. Standard monitoring included an ECG, non-invasive blood pressure, end-tidal partial pres

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are scheduled to undergo elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: A. Patients who do not sign a written informed consent B. Patients with uding of steroid medication within the last 24 hours C. Patients who receving medication known to infulence neuromuscular function such as furosemide, magnesium or cephalosporin D. Patients with neuromuscular disease, diabetics, receving chronic steroid medication due to cheonic disease E. expected difficult mask ventilation or intubation F. with an allergy to cisatracurium and dexmethasone G. pregnant , breastfeeding women, or women who Will be getting pregnant H. BMI > 25% I. Aged under 20 or over 65 years

Design outcomes

Primary

Measure	Time frame
Onset time (OT)	—

Secondary

Measure	Time frame
25% of action duration (dur25);Recovery index (RI);Recovery time (RT)	—

Countries

Korea, Republic of

Contacts

Public ContactDONG WOO KIM

Chosun University Hospital

Outcome results